{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:12:25Z","timestamp":1791637945727,"version":"4.3.4"},"reference-count":33,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T00:00:00Z","timestamp":1180051200000},"content-version":"vor","delay-in-days":1149,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2004,4]]},"abstract":"<jats:p> <jats:italic>Approximately 40% of Japanese patients with essential hypertension, including low\u2010renin hypertension, are inadequately managed. Low\u2010renin hypertension generally responds poorly to angiotensin\u2010converting enzyme inhibitors and angiotensin\u2010receptor blockers, but may respond more optimally to diuretics, calcium channel blockers, and aldosterone blockers. This multicenter, randomized, double\u2010blind, placebo\u2010controlled, parallel\u2010group, dose\u2010ranging study evaluated the efficacy and safety of the selective aldosterone blocker eplerenone in 193 Japanese patients with essential hypertension. Although not a study inclusion criterion, baseline active plasma renin levels were consistently low (5.7\u201310.1 mU\/L); most patients met the criteria for low\u2010renin hypertension (\u226442.5 mU\/L; normal range, 7\u201376 mU\/L). Patients received placebo or eplerenone 50, 100, or 200 mg once daily for 8 weeks. Systolic blood pressure decreased significantly (\u22126.8 to \u221210.6 mm Hg vs. \u22122.1 mm Hg;<\/jats:italic> p<jats:italic>\u22640.0245 vs. placebo) at all eplerenone doses; diastolic pressure decreased significantly at 100 and 200 mg doses (\u22126.9 to \u22127.5 mm Hg vs. \u22123.0 mm Hg;<\/jats:italic> p<jats:italic>\u22640.0022 vs. placebo). Eplerenone offers significant blood pressure reduction with good tolerability in Japanese patients with hypertension, including those with low\u2010renin hypertension.<\/jats:italic><\/jats:p>","DOI":"10.1111\/j.1524-6175.2004.03146.x","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T16:03:14Z","timestamp":1180108994000},"page":"175-185","source":"Crossref","is-referenced-by-count":41,"title":["Efficacy and Safety of the Selective Aldosterone Blocker Eplerenone in Japanese Patients With Hypertension: A Randomized, Double\u2010Blind, Placebo\u2010Controlled, Dose\u2010Ranging Study"],"prefix":"10.1111","volume":"6","author":[{"given":"Takao","family":"Saruta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Ogihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Hiwada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuji","family":"Tawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Gatlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Garthwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,5,25]]},"reference":[{"key":"e_1_2_15_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.82.1.57"},{"key":"e_1_2_15_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.10.1056"},{"key":"e_1_2_15_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.5.1730"},{"key":"e_1_2_15_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045415-200203000-00008"},{"key":"e_1_2_15_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(97)91058-X"},{"key":"e_1_2_15_7_2","first-page":"63","article-title":"Spironolactone in the management of congestive heart failure: a review","volume":"9","author":"Muller J","year":"1986","journal-title":"Clin Ther"},{"key":"e_1_2_15_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/26.7.671"},{"key":"e_1_2_15_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.1.451"},{"key":"e_1_2_15_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(97)91055-4"},{"key":"e_1_2_15_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.141.10.3871"},{"issue":"4","key":"e_1_2_15_12_2","first-page":"E657","article-title":"Determinants of cardiac fibrosis in experimental hypermineralocorticoid states","volume":"269","author":"Young M","year":"1995","journal-title":"Am J Physiol"},{"key":"e_1_2_15_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00060793-200006000-00006"},{"key":"e_1_2_15_14_2","first-page":"650","article-title":"Three new epoxy\u2010spironolactone derivatives: characterization in vivo and vitro","volume":"240","author":"Gasparo M","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_15_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00054-8"},{"key":"e_1_2_15_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)02957-6"},{"key":"e_1_2_15_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000025146.19104.FE"},{"key":"e_1_2_15_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000091405.00772.6E"},{"key":"e_1_2_15_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)02334-8"},{"key":"e_1_2_15_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000067463.13172.EA"},{"key":"e_1_2_15_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(97)00097-7"},{"key":"e_1_2_15_22_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01096.2001"},{"key":"e_1_2_15_23_2","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla CG","year":"1992","journal-title":"J Lab Clin Med"},{"key":"e_1_2_15_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)03199-0"},{"key":"e_1_2_15_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.33.1.232"},{"key":"e_1_2_15_26_2","first-page":"447","volume-title":"Calcium Antagonists in Clinical Medicine","author":"Chan JCN","year":"2002"},{"key":"e_1_2_15_27_2","volume-title":"Inspra [prescribing information]","year":"2002"},{"key":"e_1_2_15_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)02333-6"},{"key":"e_1_2_15_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00461-2"},{"key":"e_1_2_15_30_2","doi-asserted-by":"publisher","DOI":"10.1081\/CEH-120004230"},{"key":"e_1_2_15_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000174773"},{"key":"e_1_2_15_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-56-1-99"},{"key":"e_1_2_15_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(72)90160-X"},{"key":"e_1_2_15_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.13.1168"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1524-6175.2004.03146.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1524-6175.2004.03146.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:35:33Z","timestamp":1694421333000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1524-6175.2004.03146.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1111\/j.1524-6175.2004.03146.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-6175.2004.03146.x","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}